Service Change: DepoMed Changes Name to Assertio
Assertio Therapeutics, Inc. (NASDAQ: ASRT), announced that its corporate name changes from “Depomed, Inc.” to “Assertio Therapeutics, Inc.”
Economic: USA – Inflation
Inflation has been subdued for over a decade globally providing a welcome relief to consumers and frustrating central bankers. It appears that recent increases in inflation in the U.S. are about to frustrate global central bankers but, for an entirely different reason.
Merger Candidate Brief (Hunters & Hunted)
Currently, 20.2% of the overall market has an elevated probability of being involved in some level of merger, acquisition or breakup activity. This is a 1.2-point increase over the previous report. Approximately, half (54%) of the activity is expected in SmallCap alone, the other half is split between MidCap at 24% and LargeCap at 21%.
Stock Consideration Change Report
Buy/Buy Watch increases to 14% while Sell/Sell Watch drops to 30% providing slight relief to elevated expectations.
Stock Fair Value Changes
AIN, BRK/B, KMT and OFIX all earn increase in Fair Value while ASIX, BRKS, CAH, CVCO, INTL move down.